GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown
If youre considering AOD-9604 therapy, schedule a consultation with our medical team to discuss your health history, body composition goals, and whether this research peptide aligns with your metabolic optimization objectives under proper medical supervision
Limiting screen time and maintaining posture awareness throughout the day helps prevent gradual muscle imbalances that can lead to chronic problems.
PlexusDx's Precision Peptide Genetic Test identifies variants in GIPR and FTO, and MC4R genes that influence your response to GLP-1 therapy
JCI Insight 6 , e153732 (2021)
Hepatology 47, 14011415